These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 32475129)

  • 1. Inhibition of LXR signaling by SULT2B1b promotes liver regeneration after partial hepatectomy in mouse models of nonalcoholic fatty liver disease.
    Zhang X; Xu Y; Bai Q; Li X; Han J; Hou Y; Ji Y; Zhang Z
    Am J Physiol Gastrointest Liver Physiol; 2020 Jul; 319(1):G87-G96. PubMed ID: 32475129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of hydroxysteroid sulfotransferase 2B1b promotes hepatic oval cell proliferation by modulating oxysterol-induced LXR activation in a mouse model of liver injury.
    Wang Z; Yang X; Chen L; Zhi X; Lu H; Ning Y; Yeong J; Chen S; Yin L; Wang X; Li X
    Arch Toxicol; 2017 Jan; 91(1):271-287. PubMed ID: 27052460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxysterol sulfation by cytosolic sulfotransferase suppresses liver X receptor/sterol regulatory element binding protein-1c signaling pathway and reduces serum and hepatic lipids in mouse models of nonalcoholic fatty liver disease.
    Bai Q; Zhang X; Xu L; Kakiyama G; Heuman D; Sanyal A; Pandak WM; Yin L; Xie W; Ren S
    Metabolism; 2012 Jun; 61(6):836-45. PubMed ID: 22225954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytosolic sulfotransferase 2B1b promotes hepatocyte proliferation gene expression in vivo and in vitro.
    Zhang X; Bai Q; Xu L; Kakiyama G; Pandak WM; Zhang Z; Ren S
    Am J Physiol Gastrointest Liver Physiol; 2012 Aug; 303(3):G344-55. PubMed ID: 22679001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone H3K9 Demethylase JMJD2B Plays a Role in LXRα-Dependent Lipogenesis.
    Kim JH; Jung DY; Kim HR; Jung MH
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ursolic Acid, a Novel Liver X Receptor α (LXRα) Antagonist Inhibiting Ligand-Induced Nonalcoholic Fatty Liver and Drug-Induced Lipogenesis.
    Lin YN; Wang CCN; Chang HY; Chu FY; Hsu YA; Cheng WK; Ma WC; Chen CJ; Wan L; Lim YP
    J Agric Food Chem; 2018 Nov; 66(44):11647-11662. PubMed ID: 30359008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid hormone-responsive SPOT 14 homolog promotes hepatic lipogenesis, and its expression is regulated by liver X receptor α through a sterol regulatory element-binding protein 1c-dependent mechanism in mice.
    Wu J; Wang C; Li S; Li S; Wang W; Li J; Chi Y; Yang H; Kong X; Zhou Y; Dong C; Wang F; Xu G; Yang J; Gustafsson JÅ; Guan Y
    Hepatology; 2013 Aug; 58(2):617-28. PubMed ID: 23348573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of liver X receptors attenuates endotoxin-induced liver injury in mice with nonalcoholic fatty liver disease.
    Liu Y; Han X; Bian Z; Peng Y; You Z; Wang Q; Chen X; Qiu D; Ma X
    Dig Dis Sci; 2012 Feb; 57(2):390-8. PubMed ID: 21948338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic Inhibition of Epidermal Growth Factor Receptor Suppresses Nonalcoholic Fatty Liver Disease in a Murine Fast-Food Diet Model.
    Bhushan B; Banerjee S; Paranjpe S; Koral K; Mars WM; Stoops JW; Orr A; Bowen WC; Locker J; Michalopoulos GK
    Hepatology; 2019 Nov; 70(5):1546-1563. PubMed ID: 31063640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect and mechanism of Qiwei Tiexie capsule on 3T3-L1 adipocytes cells and rats with nonalcoholic fatty liver disease by regulating LXRα, PPARγ, and NF-κB-iNOS-NO signaling pathways.
    Suolang PC; Liu BQ; Chen J; De J; Nima ZB; Dunzhu CR
    J Ethnopharmacol; 2019 May; 236():316-325. PubMed ID: 30851372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of hepassocin in the development of non-alcoholic fatty liver disease.
    Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
    J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol metabolite, 5-cholesten-3β-25-diol-3-sulfate, promotes hepatic proliferation in mice.
    Zhang X; Bai Q; Kakiyama G; Xu L; Kim JK; Pandak WM; Ren S
    J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):262-70. PubMed ID: 22732306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acanthoic acid modulates lipogenesis in nonalcoholic fatty liver disease via FXR/LXRs-dependent manner.
    Han X; Cui ZY; Song J; Piao HQ; Lian LH; Hou LS; Wang G; Zheng S; Dong XX; Nan JX; Wu YL
    Chem Biol Interact; 2019 Sep; 311():108794. PubMed ID: 31421115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol Improves Recovery and Survival of Diet-Induced Obese Mice Undergoing Extended Major (80%) Hepatectomy.
    Jin X; Zimmers TA; Zhang Z; Koniaris LG
    Dig Dis Sci; 2019 Jan; 64(1):93-101. PubMed ID: 30284135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
    Zhang J; Du H; Shen M; Zhao Z; Ye X
    J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfation of 25-hydroxycholesterol by SULT2B1b decreases cellular lipids via the LXR/SREBP-1c signaling pathway in human aortic endothelial cells.
    Bai Q; Xu L; Kakiyama G; Runge-Morris MA; Hylemon PB; Yin L; Pandak WM; Ren S
    Atherosclerosis; 2011 Feb; 214(2):350-6. PubMed ID: 21146170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.
    Liou CJ; Wei CH; Chen YL; Cheng CY; Wang CL; Huang WC
    Cell Physiol Biochem; 2018; 49(5):1870-1884. PubMed ID: 30235452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered hepatic triglyceride content after partial hepatectomy without impaired liver regeneration in multiple murine genetic models.
    Newberry EP; Kennedy SM; Xie Y; Luo J; Stanley SE; Semenkovich CF; Crooke RM; Graham MJ; Davidson NO
    Hepatology; 2008 Oct; 48(4):1097-105. PubMed ID: 18697204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxyresveratrol ameliorates nonalcoholic fatty liver disease by regulating hepatic lipogenesis and fatty acid oxidation through liver kinase B1 and AMP-activated protein kinase.
    Lee JH; Baek SY; Jang EJ; Ku SK; Kim KM; Ki SH; Kim CE; Park KI; Kim SC; Kim YW
    Chem Biol Interact; 2018 Jun; 289():68-74. PubMed ID: 29702089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100A11 Promotes Liver Steatosis via FOXO1-Mediated Autophagy and Lipogenesis.
    Zhang L; Zhang Z; Li C; Zhu T; Gao J; Zhou H; Zheng Y; Chang Q; Wang M; Wu J; Ran L; Wu Y; Miao H; Zou X; Liang B
    Cell Mol Gastroenterol Hepatol; 2021; 11(3):697-724. PubMed ID: 33075563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.